Evidence map›Paper›PMID 37055180›Full record

ArticleThe Journal of neuroscience : the official journal of the Society for Neuroscience2023

Cross-Platform Synaptic Network Analysis of Human Entorhinal Cortex Identifies TWF2 as a Modulator of Dendritic Spine Length.

Courtney K Walker, Kelsey M Greathouse, Jennifer J Tuscher, Eric B Dammer, Audrey J Weber, Evan Liu, Kendall A Curtis, Benjamin D Boros, Cameron D Freeman, Jung Vin Seo and 8 more

Open access · hybridAbstract read
In one paragraph

Article in The Journal of neuroscience : the official journal of the Society for Neuroscience, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.9field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 11 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 2 institutions in 1 country.

Courtney K WalkerDepartment of Neurology, Center for Neurodegeneration and Experimental Therapeutics, University of Alabama at Birmingham, Birmingham, Alabama 35294.
Kelsey M GreathouseDepartment of Neurology, Center for Neurodegeneration and Experimental Therapeutics, University of Alabama at Birmingham, Birmingham, Alabama 35294.
Jennifer J TuscherDepartment of Neurobiology, University of Alabama at Birmingham, Birmingham, Alabama 35294.
Eric B DammerDepartment of Biochemistry, Emory University School of Medicine, Atlanta, Georgia 30322.ORCID 0000-0003-2947-7606
Audrey J WeberDepartment of Neurology, Center for Neurodegeneration and Experimental Therapeutics, University of Alabama at Birmingham, Birmingham, Alabama 35294.
Evan LiuDepartment of Neurology, Center for Neurodegeneration and Experimental Therapeutics, University of Alabama at Birmingham, Birmingham, Alabama 35294.
Kendall A CurtisDepartment of Neurology, Center for Neurodegeneration and Experimental Therapeutics, University of Alabama at Birmingham, Birmingham, Alabama 35294.
Benjamin D BorosDepartment of Neurology, Center for Neurodegeneration and Experimental Therapeutics, University of Alabama at Birmingham, Birmingham, Alabama 35294.
Cameron D FreemanDepartment of Neurology, Center for Neurodegeneration and Experimental Therapeutics, University of Alabama at Birmingham, Birmingham, Alabama 35294.
Jung Vin SeoDepartment of Neurology, Center for Neurodegeneration and Experimental Therapeutics, University of Alabama at Birmingham, Birmingham, Alabama 35294.
Raksha RamdasDepartment of Neurology, Center for Neurodegeneration and Experimental Therapeutics, University of Alabama at Birmingham, Birmingham, Alabama 35294.
Cheyenne HurstDepartment of Biochemistry, Emory University School of Medicine, Atlanta, Georgia 30322.
Duc M DuongDepartment of Biochemistry, Emory University School of Medicine, Atlanta, Georgia 30322.ORCID 0000-0001-5880-1888
Marla GearingDepartment of Pathology and Laboratory Medicine and Department of Neurology, Emory University School of Medicine, Atlanta, Georgia 30322.ORCID 0000-0002-1959-7412
Charles F MurchisonDepartment of Neurology, Center for Neurodegeneration and Experimental Therapeutics, University of Alabama at Birmingham, Birmingham, Alabama 35294.
Jeremy J DayDepartment of Neurobiology, University of Alabama at Birmingham, Birmingham, Alabama 35294.ORCID 0000-0002-7361-3399
Nicholas T SeyfriedDepartment of Biochemistry, Emory University School of Medicine, Atlanta, Georgia 30322 nseyfri@emory.edu jhersko@uab.edu.
Jeremy H HerskowitzDepartment of Neurology, Center for Neurodegeneration and Experimental Therapeutics, University of Alabama at Birmingham, Birmingham, Alabama 35294 nseyfri@emory.edu jhersko@uab.edu.
University of Alabama at Birmingham · USEmory University · US

Funding

The Goizueta Alzheimer's Disease Research CenterP30AG066511 · NIA · EMORY UNIVERSITY · PI Nicholas Thomas Seyfried · 2020 to 2026
$29.0M
Supplement to AMP-AD Brain Proteomic Network Enhancement, Validation and Translation into CSF BiomarkersU01AG061357 · NIA · EMORY UNIVERSITY · PI LEVEY, ALLAN I, SEYFRIED, NICHOLAS THOMAS · 2018 to 2022
$9.1M
Systems Genetic Analysis of Cognitive Resilience Using Multi-Parent CrossesRF1AG063755 · NIA · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI KACZOROWSKI, CATHERINE COOK · 2019 to 2021
$7.2M
Identifying therapeutic targets that confer synaptic resilience to Alzheimer's diseaseR01AG061800 · NIA · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI Christopher A. Gaiteri, Jeremy H. Herskowitz · 2018 to 2026
$6.9M
UAB Research Training Program in Neurobiology of Cognition and Cognitive DisordersT32NS061788 · NINDS · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI Farah Dominique Lubin · 2008 to 2026
$4.5M
Identifying the molecular systems, networks, and key molecules that underlie cognitive resilienceR01AG057911 · NIA · UPSTATE MEDICAL UNIVERSITY · PI GAITERI, CHRISTOPHER A. · 2017 to 2021
$3.8M
UAB Alzheimer's Disease Research CenterP20AG068024 · NIA · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI ROBERSON, ERIK D · 2020 to 2022
$3.3M
Epigenetic Control of Brain Reward SystemsDP1DA039650 · NIDA · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI DAY, JEREMY J · 2015 to 2019
$2.3M
Targeting Rho Kinases for Alzheimer's disease TherapeuticsR01AG054719 · NIA · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI HERSKOWITZ, JEREMY H. · 2017 to 2021
$1.9M
UAB Training Program In NeuroscienceT32NS095775 · NINDS · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI Erik D Roberson · 2017 to 2026
$1.6M
Tau-mediated synaptic dysfunction in age-related neurodegenerative diseasesF99AG083305 · NIA · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI WEBER, AUDREY · 2023 to 2024
$81k
Pathologic tau and dendritic spine loss in Alzheimer's diseaseF31AG067635 · NIA · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI WALKER, COURTNEY KAITLIN · 2020 to 2021
$75k
NIA NIH HHS F31 AG067635NIA NIH HHS F99 AG083305NIA NIH HHS P20 AG068024NIA NIH HHS P30 AG066511NIA NIH HHS R01 AG054719NIA NIH HHS R01 AG057911NIA NIH HHS R01 AG061800NIA NIH HHS RF1 AG063755NIA NIH HHS U01 AG061357NIDA NIH HHS DP1 DA039650NINDS NIH HHS T32 NS061788NINDS NIH HHS T32 NS095775
6 · The paper itself

Abstract

Proteomic studies using postmortem human brain tissue samples have yielded robust assessments of the aging and neurodegenerative disease(s) proteomes. While these analyses provide lists of molecular alterations in human conditions, like Alzheimer's disease (AD), identifying individual proteins that affect biological processes remains a challenge. To complicate matters, protein targets may be highly understudied and have limited information on their function. To address these hurdles, we sought to establish a blueprint to aid selection and functional validation of targets from proteomic datasets. A cross-platform pipeline was engineered to focus on synaptic processes in the entorhinal cortex (EC) of human patients, including controls, preclinical AD, and AD cases. Label-free quantification mass spectrometry (MS) data (

Indexed as

Alzheimer DiseaseNeurodegenerative DiseasesDendritic SpinesEntorhinal CortexHumansProteomicsAlzheimer's diseasedendritic spinesentorhinal cortexproteomicssynapsesystems biology

Identifiers

PMID37055180
PMCPMC10198456
OpenAlexW4365445789

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.